Aspicio Therapeutics, Inc., 2026-07-17
An SEC Form D private-offering notice from Downingtown, PA, a $200,000 filer-stated offering target in Biotech. Filed 2026-07-17. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Aspicio Therapeutics is a stealth stage, Downingtown, Pennsylvania based biologic therapy developer working on a treatment intended to promote synaptogenesis and address vision loss in dry age related macular degeneration.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- AE Resources Inc, 2026-07-22, $1M, Jamestown, PA
- CollPlant Biotechnologies Ltd, 2026-07-20, $10.4M, Rehovot
- Lost & Found Pittsburgh LLC, 2026-07-21, $205K, Mars, PA
- Precision Peptide Co Inc., 2026-07-20, $883K, Surrey, BC, Canada
- Ocean Thermal Energy Corp, 2026-07-21, $1M, Philadelphia, PA
- Principal Technologies Inc., 2026-07-17, $92K, Vancouver, BC, Canada
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.